Fedor B. Bogdanov
Moscow, MOW 115522, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Secosteroid-2-Pyrazoline Hybrids: Design, Synthesis, Biological Evaluation and Development of Therapeutic Combinations Against ERα-Positive Breast Cancer Cells.
Journal: Biomedicines
Published: October 28, 2025
A novel thiadiazole-steroid hybrid as a CYP19A1 inhibitor: Synthesis, molecular interaction analysis and assessment of steroid receptor signaling.
Journal: The Journal of steroid biochemistry and molecular biology
Published: October 10, 2025
A Novel Thiadiazole-Steroid Hybrid as a CYP19A1 Inhibitor: Synthesis, Molecular Interaction Analysis and Assessment of Steroid Receptor Signaling.
Journal: The Journal of steroid biochemistry and molecular biology
Published: October 10, 2025
A facile method for the preparation of 7,8-dihydro-4H-chromene-4,5(6H)-diones as non-aromatic cycle A analogs of isoflavones and their evaluation as antiproliferative agents.
Journal: Bioorganic chemistry
Published: May 29, 2025
Targeting HER2-Positive HCC1954 Breast Cancer Cells by Novel Thiazole-Dihydrobenzisoxazoles: In-Depth Design, Synthesis and Initial In Vitro Study.
Journal: Oncology research
Published: May 13, 2025
Secosteroid - 1,3,4-oxadiazole hybrids: Synthesis and evaluation of their activity against hormone-dependent breast cancer cells.
Journal: The Journal of steroid biochemistry and molecular biology
Published: January 20, 2025
Photochemical Metal-Free synthesis and biological Assessment of isocryptolepine analogues targeting estrogen receptor Alpha in breast cancer cells.
Journal: Bioorganic chemistry
Published: August 23, 2024
Secosteroid diacylhydrazines as novel effective agents against hormone-dependent breast cancer cells.
Journal: The Journal of steroid biochemistry and molecular biology
Published: May 23, 2024
Design and synthesis of phosphoryl-substituted steroidal pyridazines (Pho-STPYRs) as potent estrogen receptor alpha inhibitors: targeted treatment of hormone-dependent breast cancer cells.
Journal: RSC medicinal chemistry
Published: March 05, 2024
Synthesis and Biological Evaluation of Chalconesulfonamides: En Route to Proapoptotic Agents with Antiestrogenic Potency.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 31, 2023
Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase.
Journal: Pharmaceutics
Published: November 08, 2022
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells.
Journal: Investigational new drugs
Published: October 20, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026